Delamanid
-
Catalog number2280-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name(2R)-2-Methyl-6-nitro-2-[(4-{4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl}phenoxy)methyl]-2,3-dihydroimidazo[2,1-b]oxazole
-
DescriptionDelamanid is a new antituberculosis drug that inhibits mycolic acid synthesis and has shown potent in vitro and in vivo activity against drug-resistant strains of Mycobacterium tuberculosis.
-
CAS Number681492-22-8
-
Structure AvailableYes
-
Peptide sequenceNo
-
Salt FormNo
-
Molecular FormulaC₂₅H₂₅F₃N₄O₆
-
Molecular Weight534.48
-
Cell PermeableYes
-
Purity³99% ee by HPLC and >99% by LC
-
SolubilitiesDMSO
-
HandlingProtect from air and light
-
Tag LineAn antituberculosis agent
-
Storage Condition-20 ̊C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID6480466
-
SMILESCC1(CN2C=C(N=C2O1)[N+](=O)[O-])COC3=CC=C(C=C3)N4CCC(CC4)OC5=CC=C(C=C5)OC(F)(F)F
-
InChiInChI=1S/C25H25F3N4O6/c1-24(15-31-14-22(32(33)34)29-23(31)38-24)16-35-18-4-2-17(3-5-18)30-12-10-20(11-13-30)36-19-6-8-21(9-7-19)37-25(26,27)28/h2-9,14,20H,10-13,15-16H2,1H3/t24-/m1/s1
-
InChi KeyXDAOLTSRNUSPPH-XMMPIXPASA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameDelamanid
-
Alternative nameDelamanid
-